Selank for Cognitive Enhancement: Protocol, Dosing, and What to Expect

What this protocol is for

Selank is a Russian-developed nootropic peptide derived from the immune-modulator tuftsin. The mechanism runs through GABA-system modulation and BDNF (brain-derived neurotrophic factor) elevation, producing an anxiolytic effect without sedation. Selank reduces anxiety while keeping focus and cognitive function sharp. This is the molecule's load-bearing differentiator from benzodiazepines and most over-the-counter anxiolytics: anxiety down, alertness up.

The clinical pattern in user reports is consistent. Men in high-stress work or competitive environments who need anxiety control without losing the cognitive edge. Returning competitors managing pre-event nerves. Users who have tried conventional anxiolytics and disliked the cognitive blunting. Anecdotally, users report meaningful reduction in baseline anxiety within 2 to 5 days, sharper focus through high-demand periods, and stable mood over 2 to 4 week cycles. The molecule does not produce tolerance the way benzodiazepines do; cycles can be re-run with comparable effect.

Used by many in the recovery / biohacking space as a tactical, legal performance layer for cognitive demand periods. Run for specific high-demand windows (project blocks, training peaks, performance events) rather than as a continuous baseline. The non-sedating profile and clean tolerance make it one of the more reliable cognitive-support peptides; the research base is largely Russian and Eastern European clinical work rather than Western trials.

Dose for cognitive enhancement

100 to 300 mcg per dose, 1 to 3 times daily. Intranasal is the most common route (the molecule has good intranasal bioavailability); subcutaneous works but is less common. Standard intranasal rhythm: 100 mcg per nostril (200 mcg total) in the morning and again mid-afternoon. Higher daily total (up to 900 mcg) is used for more intensive cognitive support during acute high-demand periods.

Cycle length

2 to 4 weeks per cycle. Selank works best in defined high-demand windows rather than continuous use. No tolerance development with repeated cycles; can be re-run as needed with a 1 to 2 week off-window between cycles.

Stack pairings

Commonly stacked with Semax.

Expected timeline

Day 2–5: baseline anxiety reduction becomes noticeable. Focus and cognitive clarity improve in parallel. Week 1–2: stable anxiolytic effect with no sedation. Mood typically improves alongside the anxiety reduction. Week 2–4: cumulative effect on stress resilience builds; users typically report easier management of the situations that previously triggered anxiety.

Common mistakes

• Running Selank as a continuous baseline rather than for defined high-demand windows. The molecule works best in 2 to 4 week cycles for specific needs; continuous use is less effective and the mechanism is not designed for it.
• Expecting benzodiazepine-tier anxiolytic effect. Selank is meaningfully calmer than untreated anxiety but does not produce the deep sedation of benzodiazepines. The trade-off is the molecule keeps cognition sharp.
• Combining intranasal Selank with active nasal congestion or inflammation. Absorption gets unpredictable. Switch to subcutaneous for the cycle if nasal route is compromised.
• Treating Selank as a fix for anxiety driven by other factors. Sleep deprivation, overtraining, chronic stress, caffeine load: address these first. The peptide is a tactical layer, not a substitute for the lifestyle work.